Appili Historical Income Statement
| APLI Stock | CAD 0.04 0.00 0.00% |
Historical analysis of Appili Therapeutics income statement accounts such as Depreciation And Amortization of 11.4 K, Interest Expense of 2 M or Selling General Administrative of 3.5 M can show how well Appili Therapeutics performed in making a profits. Evaluating Appili Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Appili Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Appili Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Appili Therapeutics is a good buy for the upcoming year.
Appili |
About Appili Income Statement Analysis
Appili Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Appili Therapeutics shareholders. The income statement also shows Appili investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Appili Therapeutics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Appili Therapeutics. It is also known as Appili Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Appili Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Appili Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Appili Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Appili Therapeutics' Total Other Income Expense Net is very stable compared to the past year. As of the 8th of January 2025, Income Tax Expense is likely to grow to about 48.1 K, while Interest Income is likely to drop about 18.4 K.
| 2023 | 2024 | 2025 (projected) | Total Operating Expenses | 8.8M | 10.2M | 10.8M | Cost Of Revenue | 13.7K | 12.3K | 11.2K |
Appili Therapeutics income statement Correlations
Click cells to compare fundamentals
Appili Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Appili Therapeutics income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Income | 117.0K | 33.7K | 1.4M | 16.8K | 19.3K | 18.4K | |
| Depreciation And Amortization | 14.8K | 12.6K | 6.3K | 13.7K | 12.3K | 11.4K | |
| Interest Expense | 69.8K | 1.6M | 1.1M | 1.6M | 1.9M | 2.0M | |
| Selling General Administrative | 4.8M | 4.6M | 4.4M | 3.0M | 3.5M | 3.5M | |
| Selling And Marketing Expenses | 650.2K | 711.9K | 185.8K | 143.6K | 129.3K | 122.8K | |
| Gross Profit | (14.8K) | 1.4M | 327.9K | 813.7K | 935.8K | 982.6K | |
| Other Operating Expenses | 16.3M | 24.9M | 8.1M | 8.9M | 10.2M | 10.8M | |
| Operating Income | (16.3M) | (24.7M) | (7.9M) | (8.0M) | (7.2M) | (7.6M) | |
| Ebit | (16.3M) | (23.5M) | (7.7M) | (8.0M) | (7.2M) | (7.6M) | |
| Research Development | 11.5M | 21.5M | 3.8M | 5.6M | 6.5M | 7.8M | |
| Ebitda | (16.3M) | (23.5M) | (7.7M) | (8.0M) | (7.2M) | (7.6M) | |
| Total Operating Expenses | 16.3M | 24.9M | 8.1M | 8.8M | 10.2M | 10.8M | |
| Income Before Tax | (15.0M) | (25.1M) | (9.2M) | (3.7M) | (3.4M) | (3.5M) | |
| Total Other Income Expense Net | 1.3M | (401.4K) | (364.6K) | 4.3M | 4.9M | 5.2M | |
| Net Income Applicable To Common Shares | (5.4M) | (14.3M) | (25.1M) | (9.2M) | (8.3M) | (8.7M) | |
| Net Income | (14.3M) | (25.1M) | (9.2M) | (3.8M) | (3.4M) | (3.6M) | |
| Income Tax Expense | (627.9K) | 38.5K | 36.4K | 39.9K | 45.8K | 48.1K | |
| Net Interest Income | 47.1K | (1.5M) | (1.1M) | (1.6M) | (1.5M) | (1.4M) | |
| Net Income From Continuing Ops | (14.3M) | (25.1M) | (9.2M) | (3.8M) | (3.4M) | (3.6M) | |
| Reconciled Depreciation | 14.8K | 12.6K | 6.3K | 13.7K | 12.3K | 11.8K |
Pair Trading with Appili Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Appili Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appili Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Appili Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Appili Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Appili Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Appili Therapeutics to buy it.
The correlation of Appili Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Appili Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Appili Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Appili Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Appili Stock
Appili Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Appili Therapeutics shareholders. The income statement also shows Appili investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).